Clinical trial
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00332228 |
|---|---|
| Title | Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence |
| Official title | Study Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opiate Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | depot naltrexone, Compliance enhancement (CE), BNT |
| Enrollment | 125 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 1, 2006 |
| Last update posted | Oct 26, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: